David Battat - ATRION CEO
CEO
Mr. David A. Battat is President, Chief Executive Officer of Atrion Corporation since 2011.
| Age | 54 |
| Tenure | 14 years |
| Phone | 972 390 9800 |
| Web | https://www.atrioncorp.com |
David Battat Latest Insider Activity
Tracking and analyzing the buying and selling activities of David Battat against ATRION stock is an integral part of due diligence when investing in ATRION. David Battat insider activity provides valuable insight into whether ATRION is net buyers or sellers over its current business cycle. Note, ATRION insiders must abide by specific rules, including filing SEC forms every time they buy or sell ATRION'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
David Battat over six months ago Acquisition by David Battat of 310 shares of ATRION subject to Rule 16b-3 |
ATRION Management Efficiency
The company has return on total asset (ROA) of 0.0396 % which means that it generated a profit of $0.0396 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0523 %, meaning that it created $0.0523 on every $100 dollars invested by stockholders. ATRION's management efficiency ratios could be used to measure how well ATRION manages its routine affairs as well as how well it operates its assets and liabilities.ATRION currently holds 240 K in liabilities. ATRION has a current ratio of 7.0, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about ATRION's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Found 11 records | CEO Age | ||
| James Clemmer | AngioDynamics | 61 | |
| Amir Aghdaei | Envista Holdings Corp | 65 | |
| Brian McKelligon | Akoya Biosciences | 56 | |
| Paul Keel | Envista Holdings Corp | 55 | |
| Linda Tharby | Repro Med Systems | 57 | |
| Albert III | The Cooper Companies, | 55 | |
| Albert White | The Cooper Companies, | 51 | |
| Robert Weiss | The Cooper Companies, | 74 | |
| Michael Carrel | AtriCure | 54 | |
| Christopher Simon | Haemonetics | 61 | |
| Stephan Tanda | AptarGroup | 60 | |
Management Performance
| Return On Equity | 0.0523 | |||
| Return On Asset | 0.0396 |
ATRION Leadership Team
Elected by the shareholders, the ATRION's board of directors comprises two types of representatives: ATRION inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ATRION. The board's role is to monitor ATRION's management team and ensure that shareholders' interests are well served. ATRION's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ATRION's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Emile Battat, Executive Chairman, Member of Executive Committee and Chairman of Halkey-Roberts Corporate | ||
| David Battat, CEO and President and President of Halkey-Roberts Corporate | ||
| Jeffery Strickland, CFO, Principal Accounting Officer, VP, Secretary and Treasurer | ||
| Cindy Ferguson, Controller |
ATRION Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ATRION a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0523 | |||
| Return On Asset | 0.0396 | |||
| Profit Margin | 0.07 % | |||
| Operating Margin | 0.01 % | |||
| Current Valuation | 809.44 M | |||
| Shares Outstanding | 1.76 M | |||
| Shares Owned By Insiders | 23.36 % | |||
| Shares Owned By Institutions | 71.86 % | |||
| Number Of Shares Shorted | 44.46 K | |||
| Price To Earning | 33.22 X |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in ATRION Stock
If you are still planning to invest in ATRION check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ATRION's history and understand the potential risks before investing.
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Stocks Directory Find actively traded stocks across global markets |